Previous studies have investigated the association of CAD and the downstream mediators of the AhR signaling pathway, CYP1A1, GSTT1 and GSTM1, that mediate the metabolism of allogenic toxic substances (Table I). The gene discussed is AHR; the disease is coronary artery disorder.